Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
NCT: NCT06904365 · ACTIVE_NOT_RECRUITING
Brief Summary
Female patients with early onset (\<50 years old) pelvic malignancies such as uterine and rectal cancers are rising in incidence, which often requires pelvic radiation; many of these patients are premenopausal and at a high risk of premature ovarian failure from radiotherapy. Premature ovarian failure carries significant cardiac, musculoskeletal, sexual, and psychosocial morbidity. Ovarian transposition carries variable success rates, is not readily accessible to the general population, and can still be at risk of clinically significant radiotherapy doses. There is an unmet need for innovative techniques to protect ovarian function.
Frequently Asked Questions
What is Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women?
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women is a clinical trial registered under NCT06904365. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06904365?
The current status of NCT06904365 (Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women) is: ACTIVE_NOT_RECRUITING.
When did Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women start?
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women started on 2025-04-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.